计算机断层扫描偶发性甲状腺结节:流行率、随访与恶性风险的系统综述与Meta分析
Incidental Thyroid Nodules on Computed Tomography: A Systematic Review and Meta-Analysis Examining Prevalence, Follow-Up, and Risk of Malignancy
DOI 原文链接
用sci-hub下载
如无法下载,请从 Sci-Hub 选择可用站点尝试。
影响因子:6.7
分区:医学1区 Top / 内分泌学与代谢1区
发表日期:2024 Nov
作者:
Zhixing Song, Christopher Wu, Julia Kasmirski, Andrea Gillis, Jessica Fazendin, Brenessa Lindeman, Herbert Chen
DOI:
10.1089/thy.2024.0313
摘要
背景:计算机断层扫描(CT)应用的增加导致甲状腺偶发结节的检出率升高。目前尚无广泛认可的管理指南。本研究旨在调查由CT检测到的甲状腺偶发结节的流行率、随访实践及恶性风险(ROM)。方法:我们在PubMed、Embase和Cochrane数据库中进行全面检索,筛选2024年4月12日之前发表的相关研究(PROSPERO编号#42024535501)。纳入报道CT检测到的甲状腺偶发结节的流行率、随访及恶性风险的研究。采用随机效应模型进行合并比例分析。偏倚风险通过Cochrane随机试验偏倚风险工具(RoB 2)和纽卡斯尔-沃伦斯标准(NOS)评估。根据结节大小、CT区域和研究人群年龄等特征进行亚组分析。结果:共纳入38项研究,涉及195,959例患者,发现CT中的甲状腺偶发结节流行率为8.3%(95%置信区间[CI],7.4-9.3)。颈部CT的检出率(16.5%,CI,11.0-22.1)高于胸部CT(6.6%,CI,5.3-7.9)。多发结节占27.0%(CI,12.9-41.1)。其中,≥1cm的结节占46.3%(CI,32.3-60.3),≥1.5cm占28.6%(CI,19.9-37.3)。行超声、活检和手术的比例分别为34.9%(CI,26.1-43.7)、28.4%(CI,19.9-36.9)和8.2%(CI,2.1-14.4)。另外,25项研究中涉及6,272例患者,报道CT检测到的结节恶性率(ROM)为3.9%(CI,3.0-4.9)。≥1cm(11.7%,CI,3.9-19.4)和≥1.5cm(24.9%,CI,0-52.7)的结节ROM显著高于<1cm(0.1%,CI,0-0.8)和<1.5cm(0%,CI,0-0.2)。结论:大多数CT检测到的甲状腺偶发结节为良性。建议放射科医生与甲状腺专家合作制定管理高危结节的规范流程,以确保合理随访和优化患者护理。
Abstract
Background: The increased utilization of computed tomography (CT) has led to a higher detection rate of thyroid incidentalomas. Currently, there are no widely agreed-upon guidelines for managing these incidentalomas. This study aims to investigate the prevalence, follow-up practices, and malignancy rates of thyroid incidentalomas detected by CT. Methods: We conducted a comprehensive search of PubMed, Embase, and Cochrane databases to identify relevant studies published before April 12, 2024 (PROSPERO #42024535501). Studies reporting on the prevalence, follow-up, and risk of malignancy (ROM) of thyroid incidentalomas detected by CT were included. Combined outcomes were analyzed using pooled proportion with a random-effects model. The risk of bias was assessed using the Cochrane risk-of-bias tool for randomized trials (RoB 2) and the Newcastle-Ottawa Scale tool. Subgroup analyses were conducted based on characteristics including size of the incidentaloma, CT area, and age of the study population. Results: Thirty-eight studies involving 195,959 patients were included in the prevalence analysis, revealing a prevalence of thyroid incidentalomas on CT of 8.3% (confidence interval [CI], 7.4-9.3). The prevalence was higher in neck CT (16.5%, CI, 11.0-22.1) compared with chest CT (6.6%, CI, 5.3-7.9). Multiple incidentalomas were found in 27.0% (CI, 12.9-41.1) of patients. Of the nodules, 46.3% (CI, 32.3-60.3) were ≥1 cm, and 28.6% (CI, 19.9-37.3) were ≥1.5 cm. Thyroid ultrasounds, biopsies, and surgeries were performed in 34.9% (CI, 26.1-43.7), 28.4% (CI, 19.9-36.9), and 8.2% (CI, 2.1-14.4) of cases, respectively. Additionally, 25 studies with 6272 patients reported a ROM of 3.9% (CI, 3.0-4.9) for thyroid incidentalomas detected on CT. A higher ROM was observed in incidentalomas ≥1 cm (11.7%, CI, 3.9-19.4) and ≥1.5 cm (24.9%, CI, 0-52.7) compared with those <1 cm (0.1%, CI, 0-0.8) and <1.5 cm (0%, CI, 0-0.2). Conclusions: Most thyroid incidentalomas identified on CT are benign. Implementing a collaborative protocol between radiologists and thyroid specialists to manage high-risk thyroid incidentalomas can ensure appropriate follow-up and optimal patient care.